Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference50 articles.
1. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS);The CONSENSUS Trial Study Group;N. Engl. J. Med.,1987
2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure;The SOLVD Investigators;N. Engl. J. Med.,1991
3. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure;Cohn;N. Engl. J. Med.,2001
4. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial;Granger;Lancet,2003
5. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial;McMurray;Lancet,2003
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Angiotensin receptor blocker-neprilysin inhibitor for heart failure with reduced ejection fraction;Pharmacological Research;2024-06
2. Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts;Revista Española de Cardiología (English Edition);2023-10
3. Optimización de los tratamientos de la insuficiencia cardiaca con fracción de eyección reducida en la práctica diaria: propuesta de un grupo de expertos;Revista Española de Cardiología;2023-10
4. The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure;Frontiers in Cardiovascular Medicine;2023-05-18
5. Recurrent hypotension induced by sacubitril/valsartan in cardiomyopathy secondary to Duchenne muscular dystrophy: A case report;World Journal of Clinical Cases;2019-12-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3